首页> 外文OA文献 >Synthesis of 4,6-dideoxy-3-fluoro-2-keto-beta-D-glucopyranosyl analogues of 5-fluorouracil, N6-benzoyl adenine, uracil, thymine, N4-benzoyl cytosine and evaluation of their antitumor activities
【2h】

Synthesis of 4,6-dideoxy-3-fluoro-2-keto-beta-D-glucopyranosyl analogues of 5-fluorouracil, N6-benzoyl adenine, uracil, thymine, N4-benzoyl cytosine and evaluation of their antitumor activities

机译:5-氟尿嘧啶,N6-苯甲酰基腺嘌呤,尿嘧啶,胸腺嘧啶,N4-苯甲酰基胞嘧啶的4,6-二脱氧-3-氟-2-酮-β-D-吡喃葡萄糖基类似物的合成及其抗肿瘤活性的评估

摘要

The synthesis of the unsaturated 4,6-dideoxy-3-fluoro-2-keto-beta-d-glucopyranosyl nucleosides of 5-fluorouracil (6a), N(6)-benzoyl adenine (6b), uracil (6c), thymine (6d) and N(4)-benzoyl cytosine (6e), is described. Monoiodination of compounds 1a,b, followed by acetylation, catalytic hydrogenation and finally regioselective 2'-O-deacylation afforded the partially acetylated dideoxynucleoside analogues of 5-fluorouracil (5a) and N(6)-benzoyl adenine (5b), respectively. Direct oxidation of the free hydroxyl group at the 2'-position of 5a,b, with simultaneous elimination reaction of the beta-acetoxyl group, afforded the desired unsaturated 4,6-dideoxy-3-fluoro-2-keto-beta-D-glucopyranosyl derivatives 6a,b. Compounds 1c-e were used as starting materials for the synthesis of the dideoxy unsaturated carbonyl nucleosides of uracil (6c), thymine (6d) and N(4)-benzoyl cytosine (6e). Similarly a protection-selective deprotection sequence followed by oxidation of the free hydroxyl group at the 2'-position of the dideoxy benzoylated analogues 9c-e with simultaneous elimination reaction of the beta-benzoyl group, gave the desired nucleosides 6c-e. None of the compounds was inhibitory to a broad spectrum of DNA and RNA viruses at subtoxic concentrations. The 5-fluorouracil derivative 6a was more cytostatic (50% inhibitory concentration ranging between 0.2 and 12 microM) than the other compounds.
机译:5-氟尿嘧啶(6a),N(6)-苯甲酰基腺嘌呤(6b),尿嘧啶(6c),胸腺嘧啶的不饱和4,6-二脱氧-3-氟-2-酮-β-d-吡喃葡萄糖基核苷的合成(6d)和N(4)-苯甲酰基胞嘧啶(6e)被描述。化合物1a,b的单碘化,然后进行乙酰化,催化氢化,最后进行区域选择性的2'-O-脱酰,分别得到了5-氟尿嘧啶(5a)和N(6)-苯甲酰基腺嘌呤(5b)的部分乙酰化双脱氧核苷类似物。在5a,b的2'-位上的游离羟基直接氧化,同时消除β-乙酰氧基,得到所需的不饱和4,6-二脱氧-3-氟-2-酮-β-D -吡喃葡萄糖基衍生物6a,b。化合物1c-e用作合成尿嘧啶(6c),胸腺嘧啶(6d)和N(4)-苯甲酰基胞嘧啶(6e)的双脱氧不饱和羰基核苷的原料。类似地,保护-选择性的脱保护序列,接着在双脱氧苯甲酰化类似物9c-e的2'-位上的游离羟基被氧化,同时β-苯甲酰基的消除反应,得到了所需的核苷6c-e。在低毒浓度下,没有一种化合物能抑制广谱的DNA和RNA病毒。 5-氟尿嘧啶衍生物6a具有比其他化合物更高的细胞抑制作用(50%抑制浓度在0.2和12 microM之间)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号